Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
32,987
Sort by:
Hypercholesterolemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hypercholesterolemia Key assessments Patient Segmentation in Hypercholesterolemia Hypercholesterolemia Risk & Burden Factors driving growth in a specific Hypercholesterolemia patient population
January 2022
60 pages
Insomnia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Insomnia Key assessments Patient Segmentation in Insomnia Insomnia Risk & Burden Factors driving growth in a specific Insomnia patient population
January 2022
60 pages
Irritable Bowel Syndrome (IBS) - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Irritable Bowel Syndrome (IBS) Key assessments Patient Segmentation in Irritable Bowel Syndrome (IBS) Irritable Bowel Syndrome (IBS) Risk & Burden Factors driving growth in a specific Irritable Bowel Syndrome (IBS) patient ...
January 2022
60 pages
Juvenile Idiopathic arthritis (JIA) - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in Juvenile Idiopathic arthritis (JIA) Key assessments Patient Segmentation in Juvenile Idiopathic arthritis (JIA) Juvenile Idiopathic arthritis (JIA) Risk & Burden Factors driving growth in a specific Juvenile Idiopathic arthritis (JIA) patient population
January 2022
60 pages
Kawasaki Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Kawasaki Disease Key assessments Patient Segmentation in Kawasaki Disease Kawasaki Disease Risk & Burden Factors driving growth in a specific Kawasaki Disease patient population
January 2022
60 pages
Larynx Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Larynx Cancer Key assessments Patient Segmentation in Larynx Cancer Larynx Cancer Risk & Burden Factors driving growth in a specific Larynx Cancer patient population
January 2022
60 pages
Late-stage chronic kidney disease (CKD) - Epidemiology Forecast to 2032
US$ 3,950.00
... Forecast 7MM Coverage Total Cases in Late-stage chronic kidney disease (CKD) Key assessments Patient Segmentation in Late-stage chronic kidney disease (CKD) Late-stage chronic kidney disease (CKD) Risk & Burden Factors driving growth in a specific Late-stage chronic kidney disease (CKD) patient population ...
January 2022
60 pages
Lennox Gastaut Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Lennox Gastaut Syndrome Key assessments Patient Segmentation in Lennox Gastaut Syndrome Lennox Gastaut Syndrome Risk & Burden Factors driving growth in a specific Lennox Gastaut Syndrome patient population
January 2022
60 pages
Lip and Oral Cavity Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Lip and Oral Cavity Cancer Key assessments Patient Segmentation in Lip and Oral Cavity Cancer Lip and Oral Cavity Cancer Risk & Burden Factors driving growth in a specific Lip and Oral Cavity Cancer patient population ...
January 2022
60 pages
Liver cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Liver cancer Key assessments Patient Segmentation in Liver cancer Liver cancer Risk & Burden Factors driving growth in a specific Liver cancer patient population
January 2022
60 pages
Liver Cirrhosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Liver Cirrhosis Key assessments Patient Segmentation in Liver Cirrhosis Liver Cirrhosis Risk & Burden Factors driving growth in a specific Liver Cirrhosis patient population
January 2022
60 pages
Major Depressive Disorder - Epidemiology Forecast to 2032
US$ 3,950.00
... respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Major Depressive Disorder Key assessments Patient Segmentation in Major Depressive Disorder Major Depressive Disorder Risk & Burden Factors driving growth in a specific Major Depressive Disorder patient population
January 2022
60 pages
Meningitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Meningitis Key assessments Patient Segmentation in Meningitis Meningitis Risk & Burden Factors driving growth in a specific Meningitis patient population
January 2022
60 pages
Methicillin-resistant Staphylococcus aureus (MRSA) - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Methicillin-resistant Staphylococcus aureus (MRSA) Key assessments Patient Segmentation in Methicillin-resistant Staphylococcus aureus (MRSA) Methicillin-resistant Staphylococcus aureus (MRSA) Risk & Burden Factors driving ...
January 2022
60 pages
Migraine - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Migraine Key assessments Patient Segmentation in Migraine Migraine Risk & Burden Factors driving growth in a specific Migraine patient population
January 2022
60 pages
Multiple Myeloma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Multiple Myeloma Key assessments Patient Segmentation in Multiple Myeloma Multiple Myeloma Risk & Burden Factors driving growth in a specific Multiple Myeloma patient population
January 2022
60 pages
Multiple Sclerosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Multiple Sclerosis Key assessments Patient Segmentation in Multiple Sclerosis Multiple Sclerosis Risk & Burden Factors driving growth in a specific Multiple Sclerosis patient population
January 2022
60 pages
Myelodysplastic Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Myelodysplastic Syndrome Key assessments Patient Segmentation in Myelodysplastic Syndrome Myelodysplastic Syndrome Risk & Burden Factors driving growth in a specific Myelodysplastic Syndrome patient population
January 2022
60 pages
Myelofibrosis (MF) - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... (MF) Pipeline Analysis Myelofibrosis (MF) Market Size and Trends Myelofibrosis (MF) Market Opportunities Impact of upcoming Therapies in Myelofibrosis (MF) Myelofibrosis (MF) Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Myelofibrosis (MF) - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Myelofibrosis (MF) Key assessments Patient Segmentation in Myelofibrosis (MF) Myelofibrosis (MF) Risk & Burden Factors driving growth in a specific Myelofibrosis (MF) patient population
January 2022
60 pages
Myocardial Infarction - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Myocardial Infarction Key assessments Patient Segmentation in Myocardial Infarction Myocardial Infarction Risk & Burden Factors driving growth in a specific Myocardial Infarction patient population
January 2022
60 pages
Neuroendocrine Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Neuroendocrine Carcinoma Report Assessment Current Treatment Practices in Neuroendocrine Carcinoma Unmet Needs in Neuroendocrine Carcinoma Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2022
200 pages
Neuropathic Pain - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Neuropathic Pain Key assessments Patient Segmentation in Neuropathic Pain Neuropathic Pain Risk & Burden Factors driving growth in a specific Neuropathic Pain patient population
January 2022
60 pages
Nocturnal Enuresis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Nocturnal Enuresis Key assessments Patient Segmentation in Nocturnal Enuresis Nocturnal Enuresis Risk & Burden Factors driving growth in a specific Nocturnal Enuresis patient population
January 2022
60 pages
Non-Hodgkin's Lymphoma (NHL) - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Non-Hodgkin’s Lymphoma (NHL) Report Assessment Current Treatment Practices in Non-Hodgkin’s Lymphoma (NHL) Unmet Needs in Non-Hodgkin’s Lymphoma (NHL) Market Attractiveness Market Drivers and Barriers KEY ...
January 2022
200 pages
Non-Hodgkin's Lymphoma (NHL) - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Non-Hodgkin’s Lymphoma (NHL) Key assessments Patient Segmentation in Non-Hodgkin’s Lymphoma (NHL) Non-Hodgkin’s Lymphoma (NHL) Risk & Burden Factors driving growth in a specific Non-Hodgkin’s Lymphoma (NHL) patient population
January 2022
60 pages
Obsessive-Compulsive Disorder - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Obsessive-Compulsive Disorder Key assessments Patient Segmentation in Obsessive-Compulsive Disorder Obsessive-Compulsive Disorder Risk & Burden Factors driving growth in a specific Obsessive-Compulsive Disorder patient population ...
January 2022
60 pages
Oropharyngeal Cancer - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Oropharyngeal Cancer Report Assessment Current Treatment Practices in Oropharyngeal Cancer Unmet Needs in Oropharyngeal Cancer Market Attractiveness Market Drivers and Barriers KEY ...
January 2022
200 pages
Oropharyngeal Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Oropharyngeal Cancer Key assessments Patient Segmentation in Oropharyngeal Cancer Oropharyngeal Cancer Risk & Burden Factors driving growth in a specific Oropharyngeal Cancer patient population
January 2022
60 pages
Osteoarthritis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Osteoarthritis Pipeline Analysis Osteoarthritis Market Size and Trends Osteoarthritis Market Opportunities Impact of upcoming Therapies in Osteoarthritis Osteoarthritis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Osteoarthritis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Osteoarthritis Key assessments Patient Segmentation in Osteoarthritis Osteoarthritis Risk & Burden Factors driving growth in a specific Osteoarthritis patient population
January 2022
60 pages
Osteoporosis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Osteoporosis Osteoporosis Pipeline Analysis Osteoporosis Market Size and Trends Osteoporosis Market Opportunities Impact of upcoming Therapies in Osteoporosis Osteoporosis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Osteoporosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Osteoporosis Key assessments Patient Segmentation in Osteoporosis Osteoporosis Risk & Burden Factors driving growth in a specific Osteoporosis patient population
January 2022
60 pages
Paget's Disease - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Paget's Disease Pipeline Analysis Paget's Disease Market Size and Trends Paget's Disease Market Opportunities Impact of upcoming Therapies in Paget's Disease Paget's Disease Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Paget's Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Paget's Disease Key assessments Patient Segmentation in Paget's Disease Paget's Disease Risk & Burden Factors driving growth in a specific Paget's Disease patient population
January 2022
60 pages
Pancreatic Cancer - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Cancer Pipeline Analysis Pancreatic Cancer Market Size and Trends Pancreatic Cancer Market Opportunities Impact of upcoming Therapies in Pancreatic Cancer Pancreatic Cancer Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Pancreatic Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Pancreatic Cancer Key assessments Patient Segmentation in Pancreatic Cancer Pancreatic Cancer Risk & Burden Factors driving growth in a specific Pancreatic Cancer patient population
January 2022
60 pages
Peanut Allergy - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Peanut Allergy Key assessments Patient Segmentation in Peanut Allergy Peanut Allergy Risk & Burden Factors driving growth in a specific Peanut Allergy patient population
January 2022
60 pages
Genital Warts - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Prostate cancer Pipeline Analysis Prostate cancer Market Size and Trends Prostate cancer Market Opportunities Impact of upcoming Therapies in Prostate cancer Prostate cancer Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Prostate cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Prostate cancer Key assessments Patient Segmentation in Prostate cancer Prostate cancer Risk & Burden Factors driving growth in a specific Prostate cancer patient population
January 2022
60 pages
Psoriasis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Psoriasis Psoriasis Pipeline Analysis Psoriasis Market Size and Trends Psoriasis Market Opportunities Impact of upcoming Therapies in Psoriasis Psoriasis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Psoriasis Report ...
January 2022
200 pages
Psoriasis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Psoriasis Key assessments Patient Segmentation in Psoriasis Psoriasis Risk & Burden Factors driving growth in a specific Psoriasis patient population
January 2022
60 pages
Renal cell carcinoma - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Renal cell carcinoma Report Assessment Current Treatment Practices in Renal cell carcinoma Unmet Needs in Renal cell carcinoma Market Attractiveness Market Drivers and Barriers KEY ...
January 2022
200 pages
Renal cell carcinoma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Renal cell carcinoma Key assessments Patient Segmentation in Renal cell carcinoma Renal cell carcinoma Risk & Burden Factors driving growth in a specific Renal cell carcinoma patient population
January 2022
60 pages
Respiratory syncytial virus (RSV) - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Respiratory syncytial virus (RSV) Key assessments Patient Segmentation in Respiratory syncytial virus (RSV) Respiratory syncytial virus (RSV) Risk & Burden Factors driving growth in a specific Respiratory syncytial virus (RSV ...
January 2022
60 pages
Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Rheumatoid Arthritis (RA) Report Assessment Current Treatment Practices in Rheumatoid Arthritis (RA) Unmet Needs in Rheumatoid Arthritis (RA) Market Attractiveness Market Drivers and Barriers KEY ...
January 2022
200 pages
Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2032
US$ 3,950.00
... respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Rheumatoid Arthritis (RA) Key assessments Patient Segmentation in Rheumatoid Arthritis (RA) Rheumatoid Arthritis (RA) Risk & Burden Factors driving growth in a specific Rheumatoid Arthritis (RA) patient population
January 2022
60 pages
Schizophrenia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Schizophrenia Key assessments Patient Segmentation in Schizophrenia Schizophrenia Risk & Burden Factors driving growth in a specific Schizophrenia patient population
January 2022
60 pages
Sickle Cell Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Sickle Cell Disease Key assessments Patient Segmentation in Sickle Cell Disease Sickle Cell Disease Risk & Burden Factors driving growth in a specific Sickle Cell Disease patient population
January 2022
60 pages
